Use of metabolic imaging to monitor heterogeneity of tumour response following therapeutic mTORC1/2 pathway inhibition. (2025)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1242/dmm.050804
PubMed Identifier: 40019006
Publication URI: http://europepmc.org/abstract/MED/40019006
Type: Journal Article/Review
Volume: 18
Parent Publication: Disease models & mechanisms
Issue: 2
ISSN: 1754-8403